Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.89
-0.03-0.61%
Last update: Oct 12, 1:23 PM
$5.05
0.132.64%
Savara Inc (SVRA) Stock Price, Quote, News & History
SVRANASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Savara (NASDAQ:SVRA) through any online brokerage.
Other companies in Savara’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Savara has a consensus price target of $8.71.
The stock price for Savara (NASDAQ: SVRA) is $4.89 last updated October 12, 2026 at 1:23 PM EDT.
There are no upcoming dividends for Savara.
Savara does not have any upcoming earnings scheduled.
There is no upcoming split for Savara.
Savara is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
